Cormedix (CRMD)Deerfield Management Company, L.P. opened a new position $38.7M

3.32M

Shares reported

0.64%

Disclosed portfolio weight

$38.7M

Reported value

Holdings as of

Sep 30, 2025

Filed

Nov 14, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Sep 12, 2025InsiderDirector sold ~$131K of CRMD shares in the open market
2. Oct 20, 2025Company filing · Form 8-K · ResultsReported its results
3. Nov 12, 2025Company filing · Form 8-K · ResultsReported its results

What came next

1. Jan 5, 2026Company filing · Form 8-K · Results, Executive changeChanged a top executive or board member, and reported its results (and 1 more item)“On January 5, 2026, the Company entered into an amended and restated executive employment agreement (the “A&R Employment Agreement”) with Joseph Todisco, the Company’s Chief Executive Officer.”
2. Mar 5, 2026Company filing · Form 8-K · ResultsReported its results

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Cormedix

OQRO holds no insider, Congress, fund or contract record for Cormedix dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CRMD page.

How this filing works

• SEC Form 13F

Other disclosures at Cormedix

• SEC Form 13F-HRMay 15, 2026
• SEC Form 13F-HRMay 15, 2026
• SEC Form 13F-HRFeb 17, 2026
• SEC Form 13F-HRFeb 17, 2026
• SEC Form 13F-HRFeb 13, 2026
• SEC Form 13F-HRNov 17, 2025

Everything OQRO holds on this company is on its CRMD page.